PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Prague Lung Transplant Program, Third Department of Surgery, First Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.\', \'Institute of Pharmacology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.\', \'Department of Immunology, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.\', \'Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. Electronic address: tomas.kalina@lfmotol.cuni.cz.\', \'Department of Medical Microbiology, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1053-2498(21)02318-410.1016/j.healun.2021.05.004
?:doi
?:hasPublicationType
?:journal
  • The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
is ?:pmid of
?:pmid
?:pmid
  • 34120839
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all